NCT00860262View on ClinicalTrials.gov

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

858

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2009

Conditions
Hypertension
Interventions
DRUG

amlodipine

amlodipine 5mg for the first 2w then force titration to Amlodipine 10mg for remaining 6 w

DRUG

telmisartan

telmisartan 80mg for the 8w, no titration required

DRUG

telmisartan and amlodipine

telmisartan 80 and amlodipine 5mg for the first 2 weeks, then force titrated to telmisartan 80mg and amlodipine 10mg for the remaining 6w

Trial Locations (137)

Unknown

1235.20.525 Boehringer Ingelheim Investigational Site, Buena Park

1235.20.503 Boehringer Ingelheim Investigational Site, Long Beach

1235.20.507 Boehringer Ingelheim Investigational Site, Long Beach

1235.20.529 Boehringer Ingelheim Investigational Site, Roseville

1235.20.518 Boehringer Ingelheim Investigational Site, Tustin

1235.20.521 Boehringer Ingelheim Investigational Site, Westlake Village

1235.20.508 Boehringer Ingelheim Investigational Site, DeLand

1235.20.506 Boehringer Ingelheim Investigational Site, Hialeah

1235.20.519 Boehringer Ingelheim Investigational Site, Pembroke Pines

1235.20.523 Boehringer Ingelheim Investigational Site, Port Orange

1235.20.528 Boehringer Ingelheim Investigational Site, Blue Ridge

1235.20.516 Boehringer Ingelheim Investigational Site, North Dartmouth

1235.20.527 Boehringer Ingelheim Investigational Site, Bay City

1235.20.510 Boehringer Ingelheim Investigational Site, Las Vegas

1235.20.512 Boehringer Ingelheim Investigational Site, Albuquerque

1235.20.509 Boehringer Ingelheim Investigational Site, The Bronx

1235.20.511 Boehringer Ingelheim Investigational Site, Kettering

1235.20.515 Boehringer Ingelheim Investigational Site, Tulsa

1235.20.534 Boehringer Ingelheim Investigational Site, Medford

1235.20.526 Boehringer Ingelheim Investigational Site, Erie

1235.20.513 Boehringer Ingelheim Investigational Site, Tipton

1235.20.517 Boehringer Ingelheim Investigational Site, Providence

1235.20.522 Boehringer Ingelheim Investigational Site, Carrollton

1235.20.520 Boehringer Ingelheim Investigational Site, Houston

1235.20.530 Boehringer Ingelheim Investigational Site, Killeen

1235.20.535 Boehringer Ingelheim Investigational Site, Draper

1235.20.533 Boehringer Ingelheim Investigational Site, Magna

1235.20.505 Boehringer Ingelheim Investigational Site, Saratoga Springs

1235.20.537 Boehringer Ingelheim Investigational Site, Tacoma

1235.20.501 Boehringer Ingelheim Investigational Site, Madison

1235.20.001 Boehringer Ingelheim Investigational Site, Burgas

1235.20.002 Boehringer Ingelheim Investigational Site, Sofia

1235.20.003 Boehringer Ingelheim Investigational Site, Sofia

1235.20.005 Boehringer Ingelheim Investigational Site, Sofia

1235.20.006 Boehringer Ingelheim Investigational Site, Sofia

1235.20.007 Boehringer Ingelheim Investigational Site, Sofia

1235.20.008 Boehringer Ingelheim Investigational Site, Sofia

1235.20.009 Boehringer Ingelheim Investigational Site, Sofia

1235.20.004 Boehringer Ingelheim Investigational Site, Stara Zagora

1235.20.052 Boehringer Ingelheim Investigational Site, Benátky nad Jizerou

1235.20.059 Boehringer Ingelheim Investigational Site, Český Krumlov

1235.20.051 Boehringer Ingelheim Investigational Site, Pilsen

1235.20.053 Boehringer Ingelheim Investigational Site, Prague

1235.20.054 Boehringer Ingelheim Investigational Site, Příbram

1235.20.055 Boehringer Ingelheim Investigational Site, Slaný

1235.20.057 Boehringer Ingelheim Investigational Site, Strakonice

1235.20.058 Boehringer Ingelheim Investigational Site, Tábor

1235.20.101A Boehringer Ingelheim Investigational Site, Albens

1235.20.102F Boehringer Ingelheim Investigational Site, Arles

1235.20.103A Boehringer Ingelheim Investigational Site, Béziers

1235.20.103C Boehringer Ingelheim Investigational Site, Béziers

1235.20.103F Boehringer Ingelheim Investigational Site, Béziers

1235.20.106A Boehringer Ingelheim Investigational Site, Bourg Des Cptes

1235.20.109B Boehringer Ingelheim Investigational Site, Brivé

1235.20.108E Boehringer Ingelheim Investigational Site, Carbonne

1235.20.101D Boehringer Ingelheim Investigational Site, Chambéry

1235.20.103E Boehringer Ingelheim Investigational Site, Cournonterral

1235.20.108C Boehringer Ingelheim Investigational Site, Cugnaux

1235.20.106D Boehringer Ingelheim Investigational Site, Étrelles

1235.20.108F Boehringer Ingelheim Investigational Site, Fenouillet

1235.20.102A Boehringer Ingelheim Investigational Site, Gémenos

1235.20.102C Boehringer Ingelheim Investigational Site, Gémenos

1235.20.101C Boehringer Ingelheim Investigational Site, Grésy-sur-Aix

1235.20.108A Boehringer Ingelheim Investigational Site, Labarthe-sur-Lèze

1235.20.108B Boehringer Ingelheim Investigational Site, Labarthe-sur-Lèze

1235.20.106F Boehringer Ingelheim Investigational Site, Louvigné-de-Bais

1235.20.102E Boehringer Ingelheim Investigational Site, Marseille

1235.20.106B Boehringer Ingelheim Investigational Site, Mordelles

1235.20.107A Boehringer Ingelheim Investigational Site, Orthez

1235.20.107B Boehringer Ingelheim Investigational Site, Orthez

1235.20.107E Boehringer Ingelheim Investigational Site, Orthez

1235.20.107G Boehringer Ingelheim Investigational Site, Orthez

1235.20.109A Boehringer Ingelheim Investigational Site, Rosiers-d'Égletons

1235.20.109F Boehringer Ingelheim Investigational Site, Saint-Aulaire

1235.20.104A Boehringer Ingelheim Investigational Site, Saint-Etienne

1235.20.104D Boehringer Ingelheim Investigational Site, Saint-Etienne

1235.20.107F Boehringer Ingelheim Investigational Site, Salies-de-Béarn

1235.20.105A Boehringer Ingelheim Investigational Site, Toulon

1235.20.105D Boehringer Ingelheim Investigational Site, Toulon

1235.20.152 Boehringer Ingelheim Investigational Site, Budapest

1235.20.156 Boehringer Ingelheim Investigational Site, Budapest

1235.20.158 Boehringer Ingelheim Investigational Site, Budapest

1235.20.159 Boehringer Ingelheim Investigational Site, Budapest

1235.20.161 Boehringer Ingelheim Investigational Site, Budapest

1235.20.153 Boehringer Ingelheim Investigational Site, Gyöngyös

1235.20.154 Boehringer Ingelheim Investigational Site, Miskolc

1235.20.157 Boehringer Ingelheim Investigational Site, Miskolc

1235.20.155 Boehringer Ingelheim Investigational Site, Mosonmagyaróvár

1235.20.252 Boehringer Ingelheim Investigational Site, Brăila

1235.20.259 Boehringer Ingelheim Investigational Site, Bucharest

1235.20.262 Boehringer Ingelheim Investigational Site, Bucharest

1235.20.254 Boehringer Ingelheim Investigational Site, Iași

1235.20.261 Boehringer Ingelheim Investigational Site, Oradea

1235.20.256 Boehringer Ingelheim Investigational Site, Sibiu

1235.20.251 Boehringer Ingelheim Investigational Site, Târgu Mureş

1235.20.260 Boehringer Ingelheim Investigational Site, Tg. Mures

1235.20.253 Boehringer Ingelheim Investigational Site, Timișoara

1235.20.301 Boehringer Ingelheim Investigational Site, Moscow

1235.20.302 Boehringer Ingelheim Investigational Site, Moscow

1235.20.303 Boehringer Ingelheim Investigational Site, Moscow

1235.20.304 Boehringer Ingelheim Investigational Site, Moscow

1235.20.310 Boehringer Ingelheim Investigational Site, Moscow

1235.20.305 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.20.306 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.20.307 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.20.308 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.20.309 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.20.311 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.20.355 Boehringer Ingelheim Investigational Site, Galanta

1235.20.353 Boehringer Ingelheim Investigational Site, Košice

1235.20.352 Boehringer Ingelheim Investigational Site, Považská Bystrica

1235.20.354 Boehringer Ingelheim Investigational Site, Rimavská Sobota

1235.20.356 Boehringer Ingelheim Investigational Site, Trnava

1235.20.351 Boehringer Ingelheim Investigational Site, Vráble

1235.20.207 Boehringer Ingelheim Investigational Site, Busan

1235.20.206 Boehringer Ingelheim Investigational Site, Junam

1235.20.205 Boehringer Ingelheim Investigational Site, Koyang

1235.20.201 Boehringer Ingelheim Investigational Site, Seoul

1235.20.202 Boehringer Ingelheim Investigational Site, Seoul

1235.20.203 Boehringer Ingelheim Investigational Site, Seoul

1235.20.204 Boehringer Ingelheim Investigational Site, Seoul

1235.20.406 Boehringer Ingelheim Investigational Site, Barcelona

1235.20.408 Boehringer Ingelheim Investigational Site, Barcelona

1235.20.402 Boehringer Ingelheim Investigational Site, Granada

1235.20.403 Boehringer Ingelheim Investigational Site, Seville

1235.20.409 Boehringer Ingelheim Investigational Site, Valencia

1235.20.451 Boehringer Ingelheim Investigational Site, Kharkiv

1235.20.458 Boehringer Ingelheim Investigational Site, Kharkiv

1235.20.460 Boehringer Ingelheim Investigational Site, Kharkiv

1235.20.453 Boehringer Ingelheim Investigational Site, Kiev

1235.20.454 Boehringer Ingelheim Investigational Site, Kiev

1235.20.455 Boehringer Ingelheim Investigational Site, Kiev

1235.20.456 Boehringer Ingelheim Investigational Site, Kiev

1235.20.457 Boehringer Ingelheim Investigational Site, Kiev

1235.20.461 Boehringer Ingelheim Investigational Site, Kiev

1235.20.452 Boehringer Ingelheim Investigational Site, Lviv

1235.20.459 Boehringer Ingelheim Investigational Site, Odesa

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY